StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.30+0.06 (+1.42%)

Close on Nov 17, 2026Market cap $4.31MP/E –Yield –

Shuttle Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Shuttle Pharmaceuticals

Shuttle Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Shuttle Pharmaceuticals figures

See a number that looks wrong?